CHRISTINA PISTERZI: Open Payments
NPI 1255768966 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 29 payments from 11 companies in 2025. Trend: 2023 $354 · 2024 $524 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Dexcom, Inc. | 2 | $52 |
| Exact Sciences Corporation | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, Auvelity, Dexcom G6 Transmitter, Cologuard Collection Kit, QULIPTA, GVOKE HYPOPEN.
Industry payments across IN — which companies pay providers there.
